Panel Discussion | What Have We Learned from the Past 30 Years on the Pathophysiology of Cardiogenic Shock

Sunday, March 9, 2025

9:12 AM – 9:30 AM ET

Panel Moderator(s)

James A. Goldstein, MD, FSCAI

Director, Research and Education
Beaumont Health System
Royal Oak, Michigan, United States

Disclosure(s): ECLS Inc Licensee of Radiation Protection technology to Image Diagnostics Inc Fitchberg Mass: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)
Mitchell Krucoff, MD, FACC, FAHA, FSCAI

Professor Medicine/Cardiology
Duke University Medical Center/Duke Clinical Research Institute
Durham, North Carolina, United States

Disclosure information not submitted.
Anita R. Krueger, MD

Cardiothoracic Surgeon
Baylor Scott & White-All Saints Medical Center
Fort Worth, Texas, United States

Disclosure information not submitted.

Panel Discussant(s)

Daniel Burkhoff, MD, PhD

Director: Heart Failure, Hemodynamics and MCS Research
Cardiovascular Research Foundation
New York, New York, United States

Disclosure information not submitted.
Rafael Cavalcante, MD, PhD

Vice President, Medical Affairs
Boston Scientific
Newton, Massachusetts, United States

Disclosure information not submitted.
Lindsey Cilia, MD

Co-Director of Complex Coronary Therapeutics Program Interventional Cardiologist
Inova Heart and Vascular Institute/Virginia Heart
Falls Church, Virginia, United States

Disclosure(s): No financial relationships to disclose
Navin K. Kapur, MD, FSCAI FAHA FACC

Professor of Medicine
Tufts Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
Alexandra J. Lansky, MD, FACC, FAHA, MSCAI, FESC

Professor of Medicine
Yale School of Medicine
New Haven, Connecticut, United States

Disclosure information not submitted.
Sunil V. Mankad, MD

Director, Transesophageal Echocardiography
Mayo Clinic
Rochester, Minnesota, United States

Disclosure(s): No financial relationships to disclose
Mohit Pahuja, MD

Assistant Professor of Medicine, Division of Interventional and advanced heart failure cardiology
University of Oklahoma Medical Center
OKC, Oklahoma, United States

Disclosure(s): No financial relationships to disclose
Michael J. Rinaldi, MD

Director Structural Heart Program
Sanger Heart and Vascular Institute/Atrium Health
Charlotte, North Carolina, United States

Disclosure(s): Abbott Vascular,: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); abiomed: Consultant (Ongoing); boston scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); edwards: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

James A. Goldstein, MD, FSCAI: ECLS Inc Licensee of Radiation Protection technology to Image Diagnostics Inc Fitchberg Mass: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)

Lindsey Cilia, MD: No financial relationships to disclose

Tariq Enezate, MD: No financial relationships to disclose

Sunil V. Mankad, MD: No financial relationships to disclose

Mohit Pahuja, MD: No financial relationships to disclose

Michael J. Rinaldi, MD: Abbott Vascular,: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); abiomed: Consultant (Ongoing); boston scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); edwards: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)